Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6718)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Nov 18, 2022 (publication date) through Apr 15, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Transplantation
ISSN
2220-3230
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ouranos K, Chatziioannou A, Goulis I, Sinakos E. Role of immunotherapy in downsizing hepatocellular carcinoma prior to liver transplantation. World J Transplant 2022; 12(11): 331-346 [PMID: 36437845 DOI: 10.5500/wjt.v12.i11.331] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3230/full/v12/i11/331.htm |
| Number | Citing Articles |
| 1 |
Alexandra M. Adams, Ahmed O. Kaseb, Hop S. Tran Cao. Transplant Oncology. 2025; : 27 doi: 10.1016/B978-0-443-21901-6.00003-3
|
| 2 |
Deyuan Zhong, Ying Shi, Wenzhe Ma, Yuxin Liang, Hanjie Liu, Yingying Qin, Lu Zhang, Qinyan Yang, Xiaolun Huang, Yuanjun Lu, Jin Shang. Single‐cell profiling reveals the metastasis‐associated immune signature of hepatocellular carcinoma. Immunity, Inflammation and Disease 2024; 12(5) doi: 10.1002/iid3.1264
|
| 3 |
Shaobo Zhang, Shugeng Zhang. Successful Liver Transplantation After Achieving Complete Clinical Remission of Hepatocellular Carcinoma With Combination Therapy of Immune Checkpoint Inhibitors and Targeted Agents: A Case Report. Transplantation Proceedings 2025; 57(4): 580 doi: 10.1016/j.transproceed.2025.02.041
|
| 4 |
Hirak Pahari, Amruth Raj, Ambreen Sawant, Dipak S Ahire, Raosaheb Rathod, Chetan Rathi, Tushar Sankalecha, Sachin Palnitkar, Vikram Raut. Liver transplantation for hepatocellular carcinoma in India: Are we ready for 2040?. World Journal of Transplantation 2024; 14(1): 88833 doi: 10.5500/wjt.v14.i1.88833
Abstract(551) |
Core Tip(516) |
Full Article(HTML)(1932)
|
Full Article with Cover (PDF)-1708K(77)
|
Audio-874K(4)
|
Peer-Review Report-194K(55)
|
Answering Reviewers-170K(55)
|
Supplementary Material-181K(62)
|
Full Article (PDF)-1362K(138)
|
Full Article (XML)-204K(55)
|
Times Cited (0)
|
Total Visits (5665)
|
Open
|
| 5 |
Yi-Jie Zhang, Dian-Jie Zhou, Hong Li, Qi Pan, Ying Cheng. Prolongated and large dose of r-ATG relieves PD-L1 inhibitor-induced allograft rejection in liver transplant recipient. Hepatobiliary & Pancreatic Diseases International 2025; 24(2): 221 doi: 10.1016/j.hbpd.2024.05.005
|
| 6 |
Claudia R. Silver, Cynthia De la Garza-Ramos, John A. Stauffer, Umair Majeed, Jianfeng Wang, Beau B. Toskich. Ipilimumab and nivolumab plus radioembolization as salvage therapy for atezolizumab and bevacizumab refractory hepatocellular carcinoma resulting in complete pathologic response. Radiology Case Reports 2024; 19(11): 5024 doi: 10.1016/j.radcr.2024.07.157
|